Four Potential Biotech Market Movers to Watch Going into 2021

As we eagerly look ahead to 2021, BioSpace spoke to four biotechs hoping to seize this opportunity in the first wave of COVID-19 vaccines and therapies – or make an impact in the second. The companies’ leadership teams also reflected on the ways in which the pandemic has affected their business.